DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal Consta (Risperidone) - Gait Disturbance - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Gait Disturbance (28)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) where reactions include gait disturbance. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-13

Patient: 54 year old female

Reactions: Balance Disorder, Adverse Drug Reaction, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Thermal Burn, Fall

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Risperdal Consta

Risperdal Consta
    Dosage: 50 mg, 1 in 2 wk, intramuscular
    Indication: Schizophrenia, Paranoid Type

Risperidone
    Dosage: oral
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27

Patient: 54 year old female

Reactions: Adverse Drug Reaction, Thermal Burn, Fall, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: 50 mg, fortnight
    Indication: Schizophrenia, Paranoid Type

Risperidone
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type



Possible Risperdal Consta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27

Patient: 54 year old female

Reactions: Burning Sensation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Thermal Burn, Feeling Abnormal, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizophrenia, Paranoid Type

Risperdal Consta

Risperidone
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type

Other drugs received by patient: Vitamin B-12; Levothyroxine Sodium; Lorazepam; Multi-Vitamin



Possible Risperdal Consta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27

Patient: 54 year old female

Reactions: Adverse Drug Reaction, Fall, Thermal Burn, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: 50 mg, 2/week
    Indication: Schizophrenia, Paranoid Type

Risperidone
    Dosage: unk df, unk
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: male, weighing 98.9 kg (217.5 pounds)

Reactions: Stereotypy, Musculoskeletal Stiffness, Gait Disturbance, Crying

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Haldol
    Indication: Schizoaffective Disorder
    Start date: 2012-05-01
    End date: 2012-05-01

Haldol
    Indication: Schizophrenia
    Start date: 2012-05-01
    End date: 2012-05-01

Risperdal
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2012-05-05
    End date: 2012-06-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-05-05
    End date: 2012-06-01

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2012-05-01

Risperdal Consta
    Indication: Schizoaffective Disorder
    Start date: 2012-05-01

Risperidone
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2012-06-01

Risperidone
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-01

Other drugs received by patient: Lisinopril; Depakote; Depakote



Possible Risperdal Consta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-19

Patient: 54 year old female

Reactions: Balance Disorder, Adverse Drug Reaction, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event, Fall, Thermal Burn

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: 50 mg, 1 in 2 wk, intramuscular
    Indication: Schizophrenia, Paranoid Type

Risperidone
    Dosage: oral
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type



Possible Risperdal Consta side effects in female

Reported by a physician from United Kingdom on 2012-06-12

Patient: female

Reactions: Incorrect Dose Administered, Adverse Drug Reaction, Fall, Thermal Burn, Burning Sensation, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizophrenia, Paranoid Type

Risperidone
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in 52 year old male

Reported by a physician from Switzerland on 2012-05-14

Patient: 52 year old male

Reactions: Haemoglobin Decreased, Weight Decreased, White Blood Cell Count Decreased, Platelet Count Decreased, Gait Disturbance

Drug(s) suspected as cause:
Ethanol
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Schizophrenia, Catatonic Type
    Start date: 2003-01-01

Other drugs received by patient: Actos; Glucovance; Onglyza; Metformin HCL



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in 41 year old female

Reported by a physician from Germany on 2012-03-14

Patient: 41 year old female

Reactions: Back Pain, Ear Discomfort, Tinnitus, Nausea, Pain in Extremity, Headache, Gastric Disorder, Sleep Disorder, Gait Disturbance, Inflammation

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-01-01
    End date: 2011-05-01

Risperdal Consta
    Start date: 2011-05-01
    End date: 2011-10-01



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-03-05

Patient: male

Reactions: Confusional State, Vomiting, Pneumonia, Condition Aggravated, Gait Disturbance, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from Japan on 2012-03-02

Patient: female

Reactions: Gait Disturbance, Depression, Aggression

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in female

Reported by a physician from United Kingdom on 2012-02-22

Patient: female

Reactions: Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event, Fall, Thermal Burn

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 43 year old female

Reported by a physician from Japan on 2012-02-07

Patient: 43 year old female

Reactions: Incorrect Route of Drug Administration, Inappropriate Schedule of Drug Administration, Multi-Organ Failure, Dehydration, Gait Disturbance, Neuroleptic Malignant Syndrome, Urinary Retention, Decreased Appetite, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta

Other drugs received by patient: Levotomin; Clonazepam; Amoban



Possible Risperdal Consta side effects in female

Reported by a physician from United Kingdom on 2012-02-07

Patient: female

Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Fall, Thermal Burn

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in female

Reported by a physician from United Kingdom on 2012-01-25

Patient: female

Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Thermal Burn, Fall

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-25

Patient: female, weighing 74.8 kg (164.6 pounds)

Reactions: Agitation, Drug Ineffective, Restlessness, Dyskinesia, Hyperhidrosis, Constipation, Myalgia, Speech Disorder, Overdose, Incontinence, Insomnia, Sedation, Skin Odour Abnormal, Musculoskeletal Stiffness, Gait Disturbance

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Schizophrenia
    Start date: 2012-01-18

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-18
    End date: 2012-01-19

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-12-18
    End date: 2011-12-30



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-01-18

Patient: female

Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Fall

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 41 year old

Reported by a consumer/non-health professional from Germany on 2011-11-23

Patient: 41 year old

Reactions: Back Pain, Ear Discomfort, Tinnitus, Nausea, Pain in Extremity, Headache, Gastric Disorder, Sleep Disorder, Gait Disturbance, Inflammation

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2011-05-01
    End date: 2011-10-01

Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-01-01
    End date: 2011-05-01



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-24

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Loss of Control of Legs, Muscular Weakness, Schizophrenia, Cerebrovascular Accident, Joint Stiffness, Arthropathy, Arthralgia, Heart Rate Increased, Vision Blurred, Gait Disturbance, Arthritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizophrenia
    Start date: 2009-12-01
    End date: 2011-07-29

Risperidone
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2001-01-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017